Recent Finacing
Recent Raise
Ribbon Biolabs operates an automated enzymatic DNA synthesis platform using combinatorial optimization to assemble long subgenomic DNA (validated 10kb–20kb) and commercializes production from Vienna.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
